Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-06-25FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride from Actavis Pharma, Inc., bringing this generic product under the appro…
-
FDA approval · 2010-06-21FDA Approved: PAROXETINE HYDROCHLORIDE — Original Application (Oxford Pharmaceuticals, LLC)
FDA approved Paroxetine hydrochloride as an Original Application (ANDA) generic for Oxford Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2010-06-15Clinical Trial Update: A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression [Phase 4]
A Phase 4 study comparing duloxetine to other antidepressants for severe depression has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2010-06-08Clinical Trial Update: A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD) [Phase 4]
A Phase 4 study conducted by Massachusetts General Hospital evaluating 6(S)-5-MTHF as an add-on to SSRIs in SSRI-resistant major depressive …
-
CLINICAL_TRIALS research · 2010-06-08Clinical Trial Update: Exploring a Potential Blood Test to Diagnose Major Depressive Disorder
A completed clinical trial from Massachusetts General Hospital is exploring a potential blood test to diagnose major depressive disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-06-04Clinical Trial Update: Behavioral Activation With Depressed Adolescents [Phase 1, Phase 2]
Clinical trial update for Behavioral Activation with depressed adolescents in Phase 1 and Phase 2. Current status is unknown.
-
CLINICAL_TRIALS withdrawal · 2010-06-04Clinical Trial Update: Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical Response [NA]
The clinical trial evaluating supplementation of antidepressants with fish oil for Major Depressive Disorder has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2010-06-03Clinical Trial Update: Antidepressant Effect of Deep Brain Stimulation in Parkinson's Disease Patients [NA]
A completed trial reports evidence that deep brain stimulation may have antidepressant effects in patients with Parkinson's disease, includi…
-
CLINICAL_TRIALS trial_result · 2010-06-02Clinical Trial Update: Beta-CIT-SPECT and Neurophysiology in Depression [Phase 4]
A Phase 4 trial evaluating Beta-CIT-SPECT and neurophysiology in depression has completed, according to sponsor Ludwig-Maximilians-Universit…
-
CLINICAL_TRIALS research · 2010-05-31Clinical Trial Update: Comparison of Vitamin B12 Supplementation to Selective Serotonin Reuptake Inhibitor (SSRI) Versus SSRI Antidepressant Treatment Alone [NA]
A clinical trial is evaluating whether adding Vitamin B12 supplementation to SSRI therapy improves outcomes for Major Depressive Disorder co…
-
CLINICAL_TRIALS trial_result · 2010-05-27Clinical Trial Update: Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal Cancer [NA]
This completed trial evaluated moderate physical activity as a way to aid physical and emotional recovery in patients with stage II or stage…
-
CLINICAL_TRIALS research · 2010-05-27Clinical Trial Update: Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder [Phase 4]
This Phase 4 clinical trial compares escitalopram and reboxetine to assess gastrointestinal sensitivity in patients with major depressive di…
-
FDA approval · 2010-05-25FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for WELLBUTRIN SR (bupropion hydrochloride) submitted by GlaxoSmithKline LLC, signaling an approved …
-
FDA approval · 2010-05-19FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for fluoxetine submitted by Teva Pharmaceuticals USA, Inc. (the snippet does not specify the exact c…
-
CLINICAL_TRIALS trial_result · 2010-05-18Clinical Trial Update: The Effects of Treatment With Sertraline for Noncardiac Chest Pain [Phase 4]
Phase 4 clinical trial evaluating sertraline for noncardiac chest pain has completed. The study involves patients with panic attacks and dep…
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: Study of the Antidepressant Efficacy of a Combination Herbal Drug Preparation (NEURAPAS Balance) [Phase 3]
A Phase 3 trial evaluating the antidepressant efficacy of the herbal combination NEURAPAS Balance for depressive disorder has been terminate…
-
FDA approval · 2010-05-14FDA Approved: REMERON — Supplemental Application (Organon LLC)
FDA approved a supplemental application for REMERON (mirtazapine) from Organon LLC.
-
FDA approval · 2010-05-14FDA Approved: TRANYLCYPROMINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Tranylcypromine sulfate (Actavis Pharma, Inc.), indicating an update to the product's approval t…
-
FDA approval · 2010-05-13FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Bupropion hydrochloride from Amneal Pharmaceuticals of New York LLC, authorizing a generic v…
-
CLINICAL_TRIALS trial_result · 2010-05-07Clinical Trial Update: Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder [Phase 2]
This Phase 2 trial comparing fluoxetine alone to fluoxetine plus DU125530 in major depressive disorder has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-05-06Clinical Trial Update: Escitalopram in Adult Patients With Major Depressive Disorder [Phase 3]
A completed Phase 3 trial evaluating escitalopram in adults with major depressive disorder has posted results. The study was sponsored by Fo…
-
FDA approval · 2010-05-03FDA Approved: PROTRIPTYLINE HYDROCHLORIDE — Original Application (Sigmapharm Laboratories, LLC)
The FDA approved an original application for Protriptyline Hydrochloride as a generic antidepressant manufactured by Sigmapharm Laboratories…
-
CLINICAL_TRIALS trial_result · 2010-04-30Clinical Trial Update: Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients [Phase 4]
A Phase 4 study comparing venlafaxine XR with SSRIs and other conventional antidepressants in adults with major depressive disorder has comp…
-
FDA approval · 2010-04-27FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Actavis’s Bupropion Hydrochloride XL, extending regulatory approval for the extended-release for…
-
FDA approval · 2010-04-27FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride SR from Actavis Pharma (ANDA), authorizing the continued marketing of th…